Tag Archives: Dewey Steadman

Cardiome Pharma Gets a Buy Rating from Canaccord Genuity

Wall Street analyst has provided a review for the Healthcare company on November 14, but retained the same rating on the stock. Analyst Dewey Steadman from Canaccord Genuity reiterated a Buy rating, with a C$5 price target on November 14.

Canaccord Genuity Keeps a Hold Rating on Endo International

Canaccord Genuity analyst Dewey Steadman reiterated a Hold rating on Endo International (NASDAQ: ENDP) on November 12 and set a price target of $8. The company’s shares closed yesterday at $6.69, close to its 52-week low of $5.77. According to

Analysts Offer Insights on Consumer Goods Companies: TLTeligent Inc (NYSE: TLGT), Skyworks Solutions (NASDAQ: SWKS) and Under Armour (NYSE: UA)

Companies in the Consumer Goods sector have received a lot of coverage today as analysts weigh in on TLTeligent Inc (NYSE: TLGT), Skyworks Solutions (NASDAQ: SWKS) and Under Armour (NYSE: UA). TLTeligent Inc (NYSE: TLGT) TLTeligent Inc (NYSE: TLGT) received

Analysts Offer Insights on Healthcare Companies: ANI Pharmaceuticals Inc (NASDAQ: ANIP), LivaNova PLC (NASDAQ: LIVN) and Versartis (NASDAQ: VSAR)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on ANI Pharmaceuticals Inc (NASDAQ: ANIP), LivaNova PLC (NASDAQ: LIVN) and Versartis (NASDAQ: VSAR). ANI Pharmaceuticals Inc (NASDAQ: ANIP) In a report released today,

Canaccord Genuity Assigns a Buy Rating on Savara Inc

Canaccord Genuity analyst Dewey Steadman assigned a Buy rating to Savara Inc (NASDAQ: SVRA) yesterday and set a price target of $25. The company’s shares opened today at $9.28. Steadman said: “We see Savara’s work in NTM as meaningfully differentiated

Canaccord Genuity Remains a Buy on Aceto Corp

Canaccord Genuity analyst Dewey Steadman reiterated a Buy rating on Aceto Corp (NASDAQ: ACET) yesterday and set a price target of $15. The company’s shares closed on Friday at $10.48, close to its 52-week low of $10.27. According to TipRanks.com,